DENTSPLY SIRONA Inc
NASDAQ:XRAY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (23.8), the stock would be worth $17.83 (46% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 16.4 | $12.24 |
0%
|
| 3-Year Average | 23.8 | $17.83 |
+46%
|
| 5-Year Average | 22.8 | $17.04 |
+39%
|
| Industry Average | 19.2 | $14.39 |
+18%
|
| Country Average | 19.6 | $14.67 |
+20%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$4.2B
|
/ |
Jan 2026
$253m
|
= |
|
|
$4.2B
|
/ |
Dec 2026
$474m
|
= |
|
|
$4.2B
|
/ |
Dec 2027
$500.5m
|
= |
|
|
$4.2B
|
/ |
Dec 2028
$536.3m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
2.5B USD | 16.4 | -4.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62.4B USD | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.7T JPY | 33.7 | 38.7 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.1B CHF | 28.2 | 37.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
96.5B DKK | 15.2 | 24 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.9B USD | 20.5 | 34.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.5B GBP | 18.6 | 34.3 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 54.9 | -15.7 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.3T KRW | -79.5 | -37.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
868.9B JPY | 31.5 | 49.1 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.3B USD | 18 | 22.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
DENTSPLY SIRONA Inc
Glance View
DENTSPLY SIRONA Inc., a leading figure in the dental industry, has crafted a compelling narrative of innovation and strategic growth since its inception. The roots of this global dental solutions company can be traced back to the merger of DENTSPLY International and Sirona Dental Systems in 2016. This fusion combined strengths in dental consumables and cutting-edge equipment, creating a formidable presence in the dental market. Headquartered in Charlotte, North Carolina, with operations spanning the globe, DENTSPLY SIRONA is renowned for its comprehensive suite of dental solutions. From dental instruments and restorative materials to high-tech imaging systems and digital dental equipment, the company is at the forefront of providing holistic solutions for dental professionals. Its product line is meticulously designed to enhance clinical outcomes, improve patient experiences, and support the evolving needs of dental practices worldwide. Central to DENTSPLY SIRONA's business model is its relentless commitment to research and development, which fuels its aggressive innovations and product enhancements. This dedication to cutting-edge technology and quality assurance underpins the company's revenue streams, primarily derived from its diverse range of product segments. These encompass consumables, dental technology, and equipment solutions, which are marketed directly to dental professionals and through distributors. By capitalizing on its expansive distribution network and strategic partnerships, DENTSPLY SIRONA maintains a robust pipeline of products, ensuring steady demand and consistent economic performance in a rapidly advancing, innovation-driven industry. Through strategic acquisitions, global expansion, and a focus on education and training for dental professionals, the company continues to solidify its market position while driving forward the evolution of dental care.